Percutaneous implantation of an entirely intracardiac leadless pacemaker

New England Journal of Medicine

Volumn 373, Issue 12, 2015, Pages 1125-1135

  Reddy, Vivek Y ^a   Exner, Derek V ^c   Cantillon, Daniel J ^d   Doshi, Rahul ^e   Bunch, T Jared ^g   Tomassoni, Gery F ^h   Friedman, Paul A ⁱ   Estes, N A Mark ^j   Ip, John ^k   Niazi, Imran ^l   Plunkitt, Kenneth ^m   Banker, Rajesh ^f   Porterfield, James ⁿ   Ip, James E ^b   Dukkipati, Srinivas R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f Premier Cardiology   (United States)

^g INTERMOUNTAIN MEDICAL CENTER   (United States)

^h CENTRAL BAPTIST HOSPITAL   (United States)

ⁱ MAYO CLINIC   (United States)

^j TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k Sparrow Clinical Research Institute ^*  (United States)

^l Aurora Sinai Medical Center   (United States)

^m Naples Community Hospital Healthcare System   (United States)

ⁿ METHODIST UNIVERSITY HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CONFUSION; ADULT; AGED; ANGINA PECTORIS; ARTERIOVENOUS FISTULA; ARTICLE; ATAXIC APHASIA; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; BLEEDING; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DEVICE SAFETY; DYSARTHRIA; EQUIPMENT DESIGN; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEART ARREST; HEART PERFORATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMATOTHORAX; HUMAN; INTRACARDIAC LEADLESS PACEMAKER; LENGTH OF STAY; LETHARGY; LIMB WEAKNESS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; ORTHOSTATIC HYPOTENSION; PACEMAKER; PACEMAKER DISLODGEMENT; PACEMAKER IMPLANTATION; PERICARDITIS; PRIORITY JOURNAL; R WAVE; TREATMENT INDICATION; TREATMENT OUTCOME; ADVERSE EFFECTS; ARRHYTHMIAS, CARDIAC; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; DEVICE FAILURE; ELECTROCARDIOGRAPHY; ELECTRODE IMPLANT; INTENTION TO TREAT ANALYSIS; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTRODES, IMPLANTED; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES;

EID: 84942021935     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1507192     Document Type: Article

References (21)

1. Epstein AE, DiM arco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Comm i ttee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardio l 2008; 51(21): e1-e62.
2. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009-A World Society of Arrhythmia's project. Pac ing Clin Electrophysiol 2011; 34: 1013-27.
3. Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J 2014; 35: 1186-94.
4. Udo EO, Zuithoff NP, van Hemel NM, et al. Incidence and predictors of shortand long-term complications in pacemaker t herapy: the FOLLOWPACE study. Heart Rhythm 2012; 9: 728-35.
5. Hauser RG,Hayes DL,Kallinen LM,et al. Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prosp ective multicenter study Heart Rhythm 2007 4 154-60.
6. Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116: 1349-55.
7. Johansen JB, Jørgensen OD, Møller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection ra tes and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011; 32: 991-8.
8. Haghjoo M, Nikoo MH, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace 2007; 9: 328-32.
9. Korkeila P, Nyman K, Ylitalo A, et al. Venous obstruction after pacemaker implantation. Pacing Clin Electrophysiol 2007; 30: 199-206.
10. Palmisano P, Accogli M, Zaccaria M, et al. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy. Europace 2013; 15: 531-40.
11. Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: the ir financial implication and relation to volume and operator experience. Am J Cardiol 2000; 85: 774-6.
12. Al-Mohaissen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implanta tion of endocardial leads for pacemaker or cardioverter-defibrillator. J Am Soc Echocardiogr 2012; 25: 245-52.
13. Reddy VY, Knops RE, Sperzel JS, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation 2014; 129: 1466-71.
14. Knops RE, Tjong FVY, Neuzil P, et al. Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. J Am Coll Cardiol 2015; 65: 1497-504.
15. DeSimone CV, Friedman PA, Noheria A, et al. Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiogra phically detected patent foramen ovale. Circulation 2013; 128: 1433-41.
16. Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346: 1854-62.
17. Wilkoff BL, Bello D, Taborsky M, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart R hythm 2011; 8: 65-73.
18. Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrialbased pacing compared with ventricular pacing: meta-Analysis of randomized trials, using individual p atient data. Circulation 2006; 114: 11-7.
19. Mahapatra S, Bybee KA, Bunch TJ, et al. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm 2005; 2: 907-11.
20. Acha MR, Keaney JJ, Lubitz SA, et al. Increased perforation risk with an MRIconditional pacing lead: a single-center study. Pacing Clin Electrophysiol 2015; 38: 334-42.
21. Ritter P, Duray GZ, Steinwender C, et al. Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J 2015 June 4 (Epub ahead of print).